Clobazam Tablet
Product Images NDC 60687-423

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 60687-423). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ahp42321

FDA Label Image

Blister

Blister
This text appears to be a list of different medications called Clobazam, each with a different dosage and accompanying lot number and expiry date. However, some of the characters are not recognizable making it difficult to fully understand.*
FDA Label Image

Carton

Carton
Clobazam Tablets are available in 20 and 30 tablet packs with a prescription. Each tablet contains Clobazanm, and the usual dosage information provided in the package insert. The tablets should be stored between 20° to 25°C (68° to 77°F); however, excursions are permitted between 15° to 30°C (59 to 86°F) [see USP Controlled Foom Temperature]. This package includes a Medication Guide that must be dispensed with the product to each patient by the pharmacist. It is important to keep the tablets out of reach of children and not use them if the blister is torn or broken. The drug product in this package is manufactured by Amneal Pharmaceuticals LLG, and it is packaged and distributed by American Health Packaging in Columbus, Ohio.*
FDA Label Image

Figure 1

FDA Label Image

Figure 2

FDA Label Image

Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.